Gene · 338442
Papers1,788
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
81 to 100 of 1,788
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| The effects of microbiota-derived short-chain fatty acids on T lymphocytes: From autoimmune diseases to cancer. | Semin Oncol | 2025 | 40834607 | PubTator, text mining | PubMed |
| Indole Propionic Acid Regulates Gut Immunity: Mechanisms of Metabolite-Driven Immunomodulation and Barrier Integrity. | J Microbiol Biotechnol | 2025 | 40825672 | PubTator, text mining | PubMed |
| Intratumoral microbial community profiling identifies clinicomolecular and prognostic subtypes of colorectal cancer liver metastasis. | NPJ Precis Oncol | 2025 | 40813885 | PubTator, text mining | PubMed |
| Unraveling the Translational Relevance of β-Hydroxybutyrate as an Intermediate Metabolite and Signaling Molecule. | Int J Mol Sci | 2025 | 40806491 | PubTator, text mining | PubMed |
| Hydroxyl carboxylic acid receptor-2 (HCAR2) as a potential target in neurometabolic diseases. | Pharmacol Ther | 2025 | 40782898 | PubTator, text mining | PubMed |
| Modulation of oral vaccine efficacy by the gut microbiota. | NPJ Vaccines | 2025 | 40750603 | PubTator, text mining | PubMed |
| Probiotic-derived postbiotics: a perspective on next-generation therapeutics. | Front Nutr | 2025 | 40747333 | PubTator, text mining | PubMed |
| High-fat diet may increase the risk of insulin resistance by inducing dysbiosis. | Metabol Open | 2025 | 40741424 | PubTator, text mining | PubMed |
| The gut-bone axis in osteoporosis: a multifaceted interaction with implications for bone health. | Front Endocrinol (Lausanne) | 2025 | 40741168 | PubTator, text mining | PubMed |
| Gut microbiota-metabolome crosstalk in allergic diseases: mechanistic insights and translational opportunities. | Front Allergy | 2025 | 40735411 | PubTator, text mining | PubMed |
| Utilizing Monocarboxylate Transporter 1-Mediated Blood-Brain Barrier Penetration for Glioblastoma Positron Emission Tomography Imaging with 6-[18F]Fluoronicotinic Acid. | Mol Pharm | 2025 | 40610391 | PubTator, text mining | PubMed |
| Gut-brain-liver axis in growth hormone deficiency: role of microbiota-derived short-chain fatty acids in ethnic variability and therapeutic development. | Front Public Health | 2025 | 40520290 | PubTator, text mining | PubMed |
| Early-life antibiotic dysbiosis impairs microbial tryptophan- nicotinic acid metabolism exacerbating food allergy in adulthood. | Int Immunopharmacol | 2025 | 40403504 | PubTator, text mining | PubMed |
| GzESTY as an optimized cell-based assay for initial steps in GPCR deorphanization. | Nat Commun | 2025 | 40374633 | PubTator, text mining | PubMed |
| Not Just an Alternative Energy Source: Diverse Biological Functions of Ketone Bodies and Relevance of HMGCS2 to Health and Disease. | Biomolecules | 2025 | 40305364 | PubTator, text mining | PubMed |
| Beyond the Gut: Unveiling Butyrate's Global Health Impact Through Gut Health and Dysbiosis-Related Conditions: A Narrative Review. | Nutrients | 2025 | 40284169 | PubTator, text mining | PubMed |
| Ketone body 3-hydroxybutyrate mitigates apoptosis and enhances osteogenesis in bone organoid construction via the cAMP/PKA/CREB signaling pathway. | FASEB J | 2025 | 40277379 | PubTator, text mining | PubMed |
| Structures of G-protein coupled receptor HCAR1 in complex with Gi1 protein reveal the mechanistic basis for ligand recognition and agonist selectivity. | PLoS Biol | 2025 | 40233099 | PubTator, text mining | PubMed |
| Developing a risk assessment model for treatment-resistant schizophrenia: The role of niacin receptor GPR109A and prostaglandin receptors DP1, EP2, and EP4 in the niacin-induced flushing pathway. | Schizophr Res | 2025 | 40220605 | PubTator, text mining | PubMed |
| Prodrug Approach as a Strategy to Enhance Drug Permeability. | Pharmaceuticals (Basel) | 2025 | 40143076 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/338442/papers?page=5